211 related articles for article (PubMed ID: 38641088)
1. The molecular interplay between human and bacterial amyloids: Implications in neurodegenerative diseases.
Jain N
Biochim Biophys Acta Proteins Proteom; 2024 Jul; 1872(4):141018. PubMed ID: 38641088
[TBL] [Abstract][Full Text] [Related]
2. The menace within: bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases.
Elkins M; Jain N; Tükel Ç
Curr Opin Microbiol; 2024 Jun; 79():102473. PubMed ID: 38608623
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration.
Fernández-Calvet A; Matilla-Cuenca L; Izco M; Navarro S; Serrano M; Ventura S; Blesa J; Herráiz M; Alkorta-Aranburu G; Galera S; Ruiz de Los Mozos I; Mansego ML; Toledo-Arana A; Alvarez-Erviti L; Valle J
Nat Commun; 2024 May; 15(1):4150. PubMed ID: 38755164
[TBL] [Abstract][Full Text] [Related]
4. Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies.
Trubitsina NP; Matiiv AB; Rogoza TM; Zudilova AA; Bezgina MD; Zhouravleva GA; Bondarev SA
Biochemistry (Mosc); 2024 Mar; 89(3):523-542. PubMed ID: 38648770
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
Nohesara S; Abdolmaleky HM; Thiagalingam S; Zhou JR
Epigenomics; 2024 Jan; 16(1):57-77. PubMed ID: 38088063
[TBL] [Abstract][Full Text] [Related]
6. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease.
Pistollato F; Sumalla Cano S; Elio I; Masias Vergara M; Giampieri F; Battino M
Nutr Rev; 2016 Oct; 74(10):624-34. PubMed ID: 27634977
[TBL] [Abstract][Full Text] [Related]
7. The role of microbial amyloid in neurodegeneration.
Friedland RP; Chapman MR
PLoS Pathog; 2017 Dec; 13(12):e1006654. PubMed ID: 29267402
[TBL] [Abstract][Full Text] [Related]
8. Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.
Ma YY; Li X; Yu JT; Wang YJ
Transl Neurodegener; 2024 Feb; 13(1):12. PubMed ID: 38414054
[TBL] [Abstract][Full Text] [Related]
9. Role of Bmal1 and Gut Microbiota in Alzheimer's Disease and Parkinson's Disease Pathophysiology: The Probable Effect of Melatonin on Their Association.
Khezri MR; Esmaeili A; Ghasemnejad-Berenji M
ACS Chem Neurosci; 2023 Nov; 14(21):3883-3893. PubMed ID: 37823531
[TBL] [Abstract][Full Text] [Related]
10. The role of amyloids in Alzheimer's and Parkinson's diseases.
Salahuddin P; Fatima MT; Uversky VN; Khan RH; Islam Z; Furkan M
Int J Biol Macromol; 2021 Nov; 190():44-55. PubMed ID: 34480905
[TBL] [Abstract][Full Text] [Related]
11. Amyloid, Crohn's disease, and Alzheimer's disease - are they linked?
Duda-Madej A; Stecko J; Szymańska N; Miętkiewicz A; Szandruk-Bender M
Front Cell Infect Microbiol; 2024; 14():1393809. PubMed ID: 38779559
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
Heravi FS; Naseri K; Hu H
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
[TBL] [Abstract][Full Text] [Related]
13. Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases.
Miller AL; Bessho S; Grando K; Tükel Ç
Front Immunol; 2021; 12():638867. PubMed ID: 33717189
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
Goyal D; Ali SA; Singh RK
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
[TBL] [Abstract][Full Text] [Related]
15. Amyloids on Membrane Interfaces: Implications for Neurodegeneration.
Mahakud AK; Shaikh J; Rifa Iqbal VV; Gupta A; Tiwari A; Saleem M
J Membr Biol; 2022 Dec; 255(6):705-722. PubMed ID: 35670831
[TBL] [Abstract][Full Text] [Related]
16. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
Zheng Y; Bonfili L; Wei T; Eleuteri AM
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
[TBL] [Abstract][Full Text] [Related]
18. Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance.
Bi M; Feng L; He J; Liu C; Wang Y; Jiang H; Liu SJ
Ageing Res Rev; 2022 Dec; 82():101759. PubMed ID: 36243356
[TBL] [Abstract][Full Text] [Related]
19. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
Spielman LJ; Gibson DL; Klegeris A
Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
